Cargando…

Forced Vital Capacity (FVC) decline, mortality and healthcare resource utilization in idiopathic pulmonary fibrosis

Aim of the study: Potential care implications of antifibrotic reimbursement restrictions were studied by forced vital capacity (FVC) decline, mortality and specialty care related healthcare resource utilization in patients with idiopathic pulmonary fibrosis (IPF). Material and methods: IPF patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lassenius, Mariann I., Toppila, Iiro, Pöntynen, Nora, Kasslin, Laura, Kaunisto, Jaana, Kilpeläinen, Maritta, Laitinen, Tarja
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6968594/ https://www.ncbi.nlm.nih.gov/pubmed/32002175 http://dx.doi.org/10.1080/20018525.2019.1702618

Ejemplares similares

The Burden Of Chronic Obstructive Pulmonary Disease (COPD) In Finland: Impact Of Disease Severity And Eosinophil Count On Healthcare Resource Utilization
por: Viinanen, Arja, et al.
Publicado: (2019)

Clinical and functional correlations of the difference between slow vital capacity and FVC
por: Fernandez, Jonathan Jerias, et al.
Publicado: (2020)

Real‐world clinical diagnostics of heart failure patients with reduced or preserved ejection fraction
por: Huusko, Jenni, et al.
Publicado: (2020)

Burden of migraine in Finland: multimorbidity and phenotypic disease networks in occupational healthcare
por: Korolainen, Minna A., et al.
Publicado: (2020)

Efficacy of Idebenone to Preserve Respiratory Function above Clinically Meaningful Thresholds for Forced Vital Capacity (FVC) in Patients with Duchenne Muscular Dystrophy
por: Mayer, Oscar H., et al.
Publicado: (2017)

Comorbidity characteristics of multiple myeloma patients diagnosed in Finland 2005–2016
por: Toppila, Iiro, et al.
Publicado: (2022)

Forced Expiratory Volume in 6 s (FEV(6)) and FEV(1)/FEV(6) Values as a Viable Alternative for Forced Vital Capacity (FVC) and FEV(1)/FVC Values During Pregnancy in South East Nigeria: A Preliminary Study
por: Nwagha, U, et al.
Publicado: (2014)

Prognostic significance of forced vital capacity decline prior to and following antifibrotic therapy in idiopathic pulmonary fibrosis
por: Aono, Yuya, et al.
Publicado: (2020)

526 Relationship between Fractional Exhaled Nitric Oxide (Feno) and Forced Expiratory Volume in One Second (Fev1) and Forced Vital Capacity (Fvc)i Children with Asthma
por: Kim, Myung-Sung, et al.
Publicado: (2012)

Heart failure in Finland: clinical characteristics, mortality, and healthcare resource use
por: Huusko, Jenni, et al.
Publicado: (2019)

Burden of migraine in Finland: health care resource use, sick-leaves and comorbidities in occupational health care
por: Korolainen, Minna A., et al.
Publicado: (2019)

Consistency and reliability of smoking-related variables: longitudinal study design in asthma and COPD
por: Hirvonen, Eveliina, et al.
Publicado: (2019)

Measuring slow vital capacity to detect airflow limitation in a woman with dyspnea and a preserved FEV(1)/FVC ratio
por: Berton, Danilo Cortozi, et al.
Publicado: (2019)

SVC Is a Marker of Respiratory Decline Function, Similar to FVC, in Patients With ALS
por: Pinto, Susana, et al.
Publicado: (2019)

The Gaucher earlier diagnosis consensus point-scoring system (GED-C PSS): Evaluation of a prototype in Finnish Gaucher disease patients and feasibility of screening retrospective electronic health record data for the recognition of potential undiagnosed patients in Finland
por: Savolainen, Markku J., et al.
Publicado: (2021)

Bayesian predictors of very poor health related quality of life and mortality in patients with COPD
por: Ryynänen, Olli-Pekka, et al.
Publicado: (2013)

Modelling Forced Vital Capacity in Idiopathic Pulmonary Fibrosis: Optimising Trial Design
por: Santermans, Eva, et al.
Publicado: (2019)

Meta-Analysis of Effect of Nintedanib on Reducing FVC Decline Across Interstitial Lung Diseases
por: Bonella, Francesco, et al.
Publicado: (2022)

Physical inactivity in COPD and increased patient perception of dyspnea
por: Katajisto, Milla, et al.
Publicado: (2012)

Use of Linked Nordic Registries for Population Studies in Hematologic Cancers: The Case of Multiple Myeloma
por: Abildgaard, Niels, et al.
Publicado: (2023)

Difference between slow vital capacity and forced vital capacity in the diagnosis of airflow limitation
por: Pereira, Carlos Alberto de Castro
Publicado: (2020)

Rapid FEV(1)/FVC Decline Is Related With Incidence of Obstructive Lung Disease and Mortality in General Population
por: Choi, Kwang Yong, et al.
Publicado: (2022)

Change in forced vital capacity and associated subsequent outcomes in patients with newly diagnosed idiopathic pulmonary fibrosis
por: Reichmann, William M., et al.
Publicado: (2015)

Comparison between the disease-specific Airways Questionnaire 20 and the generic 15D instruments in COPD
por: Mazur, Witold, et al.
Publicado: (2011)

Impact of chronic fibrosing interstitial lung disease on healthcare use: association between fvc decline and inpatient hospitalization
por: Singer, David, et al.
Publicado: (2023)

Co-morbidities are the key nominators of the health related quality of life in mild and moderate COPD
por: Koskela, Jukka, et al.
Publicado: (2014)

Effect of continued treatment with pirfenidone following clinically meaningful declines in forced vital capacity: analysis of data from three phase 3 trials in patients with idiopathic pulmonary fibrosis
por: Nathan, Steven D, et al.
Publicado: (2016)

Pulmonary Sarcoidosis: Beyond Restriction and Forced Vital Capacity
por: Obi, Ogugua Ndili
Publicado: (2023)

Collagen 1a1 Expression by Airway Macrophages Increases In Fibrotic ILDs and Is Associated With FVC Decline and Increased Mortality
por: Tsitoura, Eliza, et al.
Publicado: (2021)

FVC variability in patients with idiopathic pulmonary fibrosis and role of 6-min walk test to predict further change
por: Nathan, Steven D., et al.
Publicado: (2020)

Vitality and the Vital Forces
por: Noel, H. R.
Publicado: (1870)

First Data on Efficacy and Safety of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis and Forced Vital Capacity of ≤50 % of Predicted Value
por: Wuyts, Wim A., et al.
Publicado: (2016)

Pretreatment rate of decay in forced vital capacity predicts long-term response to pirfenidone in patients with idiopathic pulmonary fibrosis
por: Biondini, Davide, et al.
Publicado: (2018)

Association of Forced Vital Capacity with the Developmental Gene NCOR2
por: Minelli, Cosetta, et al.
Publicado: (2016)

A mathematical reason for FEV1/FVC dependence on age
por: Gólczewski, Tomasz, et al.
Publicado: (2012)

Association between 25-hydroxy vitamin D and lung function (FEV1, FVC, FEV1/FVC) in children and adults with asthma: A systematic review
por: Abi-Ayad, Meryem, et al.
Publicado: (2023)

Decline in forced vital capacity in subjects with systemic sclerosis-associated interstitial lung disease in the SENSCIS trial compared with healthy reference subjects
por: Maher, Toby M., et al.
Publicado: (2022)

Comparison between reference values for FVC, FEV(1), and FEV(1)/FVC ratio in White adults in Brazil and those suggested by the Global Lung Function Initiative 2012
por: Pereira, Carlos Alberto de Castro, et al.
Publicado: (2014)

Quantification of Reduction in Forced Vital Capacity of Sand Stone Quarry Workers
por: Singh, Suresh Kumar, et al.
Publicado: (2007)

Acceptable alternatives for forced vital capacity in the spirometric diagnosis of bronchial asthma
por: Lutfi, Mohamed Faisal
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_mhh384fq1k3l95v4apotnuq1a5